Cardium Therapeutics presented its financial results for the first quarter ended March 31, and reported on highlights and other recent developments. Academy Medical has a growing customer base of over 35 Veterans Administration and military hospitals within the U.S. -Presentation at the 2013 Phacilitate Annual Cell and Gene Therapy Forum in Washing
State Health Commissioner Nirav R. Shah, M.D., M.P.H., today announced that the U.S. Food and Drug Administration has responded favorably to a petition submitted by the New York State Department of Health that is designed to make it easier for smokers to quit. In 2008, DOH became the first state health department in the nation to petition the FDA t
Release date- 23052013- Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed to be marketed for this use. The HbA1c tests, or A1c tests, currently on the marke
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 23, 2013.{ nfg} Omeros Corporation announced its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Omeros plans to advance OMS824 into Phase 2 clinical trials for Huntington's disease next
Our news journalists obtained a quote from the research from University Hospital, "The main objectives of the present study were to assess the potential impact of an intervention to promote patient reporting in community pharmacies in the Veneto region of Italy, and to compare the characteristics of patients' and general practitioners' reports of A
FDA allows marketing of first A1c test labeled for diagnosing diabetes Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed to be marketed for this use.
MedVantx, Inc., the company that has pioneered a unique direct to consumer pharmaceutical distribution channel announced today the Company has completed a major expansion of its home delivery platform to manage $1.5 B in pharmaceutical products and the upgrade of its systems to offer a level of quality akin to cGMP facilities in its specialty home
WEALTHMAKERS.COM/ www.wealthmakers.com, a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Callidus...
"South Korea Pharmaceutical Market Outlook 2013" provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The South Korean..
BUYINS.NET/ www.squeezetrigger.com is monitoring the Seasonality of Cornerstone Therapeutics Inc, EnseCo Energy Services Corp, CENTENE CORPORATION, Asbury Automotive Group Inc, Xyratex Ltd, Fibria Celulose SA and each have a high seasonal probability to go Up in the next weeks. CRTX Cornerstone Therapeutics Inc 6.75% 87.50% Wednesday, May 29th 2013
Today's alerts include: Access Pharmaceuticals, Inc.. Access Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. For additional information on Access Pharmaceuticals, visit: www.accesspharma.com.
Researchmoz presents this most up-to-date research on South Korea Pharmaceutical Market Outlook 2013. The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the South Korea Pharmaceutical Market. South Korea Pharmaceutical Market Outlook 2013? provides in-depth analysis of the trends, i
BioElectronics Corp., the maker of inexpensive, disposable drug-free consumer electronic devices, announced that CEO, Andrew J. Whelan is presenting today to the FDA' s Medical Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments for reclassifying the company's products for over the counter sales. "It's been 37 years since
Cardium Therapeutics has presented its financial results for the first quarter ended March 31, and reported on highlights and other recent developments. Academy Medical has a growing customer base of over 35 Veterans Administration and military hospitals within the U.S. -Presentation at the 2013 Phacilitate Annual Cell& Gene Therapy Forum in Washin
Synergy Pharmaceuticals 21.05. 2013 16:01- NEW YORK, 2013-05-21 16:00 CEST Synergy Pharmaceuticals Inc., a developer of new drugs to treat patients with gastrointestinal disorders and diseases, today presented positive safety and efficacy results from its large multicenter
FDA is interested in obtaining patient input on the impact of HIV on daily life, available therapies to treat the condition, and patients' views on issues related to HIV cure research, such as perceived benefits and acceptable risks for participating in HIV cure research and clear communication of benefits and risks through informed consent.
NEW YORK, May 21, 2013 Synergy Pharmaceuticals Inc., a developer of new drugs to treat patients with gastrointestinal disorders and diseases, today presented positive safety and efficacy results from its large multicenter trial of plecanatide in patients with chronic idiopathic constipation at Digestive Disease Week in Orlando, FL..
Cardium Therapeutics presented its financial results for the first quarter ended March 31, and reported on highlights and other recent developments. Academy Medical has a growing customer base of over 35 Veterans Administration and military hospitals within the U.S. -Presentation at the 2013 Phacilitate Annual Cell and Gene Therapy Forum in Washing
This quarterly report on Form 10- Q and other reports filed by the Company from time to time with the Securities and Exchange Commission contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company's management as well as estimates and assumptions made by Compa
By a News Reporter-Staff News Editor at OBGYN& Reproduction Week At the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists in New Orleans, Clearblue unveiled the newest addition to their family of products that will change women's home pregnancy test experiences forever. Cleared by the Food and Drug Administr
Twenty-five years after pharmaceutical giant Eli Lilly unleashed Prozac on the red-braced 80 s, SSRIs are still the world's most popular antidepressants. They are swallowed by more than 40 million people, from Beijing to Beirut, knitting a web of happiness from New York to New Caledonia. Like the Soma of Aldous Huxley's Brave New World, Prozac was
